Hansa Biopharma to host conference call to provide interim results for January-March 2023 and a Business Update

LUND, Sweden, April 14, 2023 /PRNewswire/ — Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-March 2023 at 8:00 CET on April 20, 2023. All interested parties are invited to participate in a telephone conference, which will include a presentation of…